KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 76 filers reported holding KEMPHARM INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $59,388 | -15.5% | 12,120 | 0.0% | 0.00% | -50.0% |
| Q1 2024 | $70,296 | -11.5% | 12,120 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $79,386 | +35.9% | 12,120 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $58,418 | -5.5% | 12,120 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $61,812 | -7.3% | 12,120 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $66,660 | +19.8% | 12,120 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $55,631 | -26.8% | 12,120 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $76,000 | +40.7% | 12,120 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $54,000 | -11.4% | 12,120 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $60,964 | -43.0% | 12,120 | -1.5% | 0.00% | -25.0% |
| Q4 2021 | $107,000 | -7.0% | 12,310 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $115,000 | -29.9% | 12,310 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $164,000 | +40.2% | 12,310 | 0.0% | 0.01% | +14.3% |
| Q1 2021 | $117,000 | – | 12,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 2,308,216 | $11,125,601 | 0.95% |
| Retirement Planning Co of New England, Inc. | 347,402 | $1,674,478 | 0.93% |
| Mystic Asset Management, Inc. | 203,283 | $979,824 | 0.55% |
| Kovack Advisors, Inc. | 124,109 | $598,208 | 0.08% |
| Arete Wealth Advisors, LLC | 80,729 | $389,114 | 0.07% |
| City State Bank | 14,224 | $69 | 0.04% |
| IFG Advisors, LLC | 12,900 | $62,178 | 0.02% |
| Measured Wealth Private Client Group, LLC | 10,000 | $48,200 | 0.02% |
| VisionPoint Advisory Group, LLC | 6,860 | $33,065 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,615 | $109,004 | 0.01% |